<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-132261" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Congenital Nephrotic Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jain</surname>
            <given-names>Jyoti B.</given-names>
          </name>
          <aff>Nassau University Medical Center, Long Island, New York</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chauhan</surname>
            <given-names>Shaylika</given-names>
          </name>
          <aff>Geisinger Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jyoti Jain declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shaylika Chauhan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-132261.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Congenital nephrotic syndrome (CNS) is defined when it presents within three months of birth. It consists of heavy proteinuria, edema, hypoalbuminemia, hypogammaglobulinemia, hypercoagulability, and hyperlipidemia. Management is very challenging as patients are prone to complications such as infection, thrombosis, and failure to thrive. This activity outlines the evaluation and treatment of congenital nephrotic syndrome and emphasizes the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of congenital nephrotic syndrome.</p></list-item><list-item><p>Review the appropriate evaluation of congenital nephrotic syndrome.</p></list-item><list-item><p>Outline the management options for congenital nephrotic syndrome.</p></list-item><list-item><p>Summarize the importance of collaboration amongst the multidisciplinary team to add to the care of patients with congenital nephrotic syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=132261&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=132261">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-132261.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Congenital nephrotic syndrome (CNS) is defined&#x000a0;when it presents within three months of birth. It consists of heavy proteinuria, edema, hypoalbuminemia, hypogammaglobulinemia, hypercoagulability, and hyperlipidemia.<xref ref-type="bibr" rid="article-132261.r1">[1]</xref>&#x000a0;The infantile nephrotic syndrome presents within&#x000a0;4&#x000a0;to 12 months, and nephrotic syndrome manifesting after one year is called childhood nephrotic syndrome.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref></p>
      </sec>
      <sec id="article-132261.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of congenital nephrotic syndrome is heterogeneous. The etiology can be divided into genetic, non-genetic, and infectious.&#x000a0;</p>
        <table-wrap id="article-132261.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p>Genetic</p>
</td>
                <td rowspan="1" colspan="1">
<p>Genetic defects including genes &#x000a0;NPHS1, NPHS2, WT1, PLCE1, and LAMB2</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Infectious</p>
</td>
                <td rowspan="1" colspan="1">
<p>Congenital syphilis and toxoplasmosis, congenital cytomegalovirus infection, HIV infection, Hepatitis B virus, and congenital rubella infection</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Non Genetic</p>
</td>
                <td rowspan="1" colspan="1">
<p>Maternal systemic lupus erythematosus, mercury poisoning, renal vein thrombosis, and neonatal alloimmunization.</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Most congenital nephrotic syndrome cases are genetic due to monogenic defects of structural proteins that form the kidney filtration barrier.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref>&#x000a0;The most common cause is the congenital nephrotic syndrome of the Finnish type (CNF). It is named due to its high incidence in Finland and is inherited as autosomal recessive.&#x000a0;Congenital nephrotic syndrome of the Finnish type is caused by a mutation in the gene&#x000a0;NPHS1 encoding nephrin, one of the structural proteins that form the kidney filtration barrier.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref>&#x000a0;As&#x000a0;<italic toggle="yes">NPHS1</italic>&#x000a0;is expressed exclusively in the kidney podocyte, congenital nephrotic syndrome of the Finnish type does not have extrarenal findings.<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
      </sec>
      <sec id="article-132261.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of congenital nephrotic syndrome is between 1&#x000a0;and 3 per 100,000 live births. Congenital nephrotic syndrome of the Finnish type, CNF, is prevalent in Finland with an incidence of 1&#x000a0;per 8,200 births.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref><xref ref-type="bibr" rid="article-132261.r5">[5]</xref><xref ref-type="bibr" rid="article-132261.r6">[6]</xref></p>
      </sec>
      <sec id="article-132261.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In&#x000a0;Congenital nephrotic syndrome of the Finnish type, the primary defect is the loss of proteins in the kidney.&#x000a0;Congenital nephrotic syndrome of the Finnish type is due to mutation of the NPHS1 gene on chromosome 19 encoding nephrin, one of the structural proteins that form the kidney filtration barrier.&#x000a0;The kidney filtration barrier has three layers of epithelial cell layer composed of (podocyte) with distal foot processes and slit diaphragms (SD) interspersed, glomerular basement membrane (GBM), and&#x000a0;fenestrated capillary endothelium.&#x000a0;Nephrin localizes to the slit diaphragm, and its defect leads to proteinuria.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref>&#x000a0;</p>
        <p>Proteinuria leads to&#x000a0;albuminuria, hypoalbuminemia, and edema. Hyperlipidemia is due to the increased lipoprotein synthesis secondary to hypoalbuminemia, which causes increased platelet aggregation and thrombosis. The loss of minerals and vitamins predispose to malnutrition and infections.<xref ref-type="bibr" rid="article-132261.r6">[6]</xref>&#x000a0;Hypothyroidism develops due to the loss of thyroid-binding globulin in the urine.<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
      </sec>
      <sec id="article-132261.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The most typical feature in the histology of congenital nephrotic syndrome of the Finnish type is irregular microcystic dilatation of the proximal tubule.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref>&#x000a0;The glomeruli are normal or may show matrix expansion and mesangial hypercellularity.<xref ref-type="bibr" rid="article-132261.r7">[7]</xref></p>
      </sec>
      <sec id="article-132261.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Prenatal and perinatal history: placental weight below 25% of newborn weight, enlarged prenatal nuchal translucency, fetal edema,&#x000a0;increased amniotic fluid alpha-fetoprotein, and&#x000a0;oligohydramnios&#x000a0;</p>
        <p>Family history: history of congenital nephrotic syndrome, consanguinity, ethnicity, early infantile death,&#x000a0; neurological and kidney diseases of infancy.</p>
        <p>Patient history: swelling, poor growth</p>
        <p>Physical examination: signs of edema (e.g., pericardial, pleural effusions, and ascites.</p>
      </sec>
      <sec id="article-132261.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Congenital nephrotic syndrome of the Finnish type can be diagnosed prenatally by elevated maternal serum alfa fetoprotein, MSAFP (&#x0003e;2.5 MoM) at the second trimester of pregnancy.</p>
        <p>Thyroid-stimulating hormone (TSH) may be normal in the beginning but typically increases during the first month.&#x000a0;Free thyroxine (T4) is low.</p>
        <p>Blood biochemistry: blood count, levels of sodium, chloride, magnesium, protein, albumin,&#x000a0; creatinine, urea, cholesterol, fasting triglycerides, and glucose.</p>
        <p>Other factors included in the evaluation include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Serum IgG level. Serum levels of&#x000a0; phosphate, ionized calcium,&#x000a0;25(OH) vitamin D3, alkaline phosphatase, and PTH</p>
          </list-item>
          <list-item>
            <p>Serum urea and creatinine levels are variable. Renal function is often normal for the first months.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>The serum analysis demonstrates hypoalbuminemia (&#x0003c;2.5&#x000a0;mg/dL and low thyroid hormone level.<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>The urinalysis demonstrates proteinuria (&#x0003e;2000&#x000a0;mg/L), hematuria, and leukocyturia with a negative urine culture.<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Ultrasound scanning shows kidneys of normal size or larger, and the renal cortex is hyperechogenic.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cardiac ultrasound (effusions and left ventricular mass)</p>
          </list-item>
        </list>
        <p>Kidney biopsy demonstrates microcystic dilatation of proximal&#x000a0;tubules, increased mesangial hypercellularity, and a mild increase in the mesangial matrix in light microscopy. Electron microscopy&#x000a0;demonstrates the effacement of podocyte foot processes.&#x000a0;<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
        <p>The modality of choice for precise&#x000a0;Congenital nephrotic syndrome of the Finnish type diagnosis is the genetic analysis&#x000a0;by detection of mutations in NPHS1.<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
      </sec>
      <sec id="article-132261.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Congenital nephrotic syndrome therapy goals are to control edema, prevent and treat complications including infections and thromboses, and provide optimal nutrition for the child to help grow. Kidney transplantation is the only curative treatment in most cases.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref></p>
        <p>
<bold>Albumin Infusions</bold>
</p>
        <p>Proteinuria leads to life-threatening complications, including&#x000a0;protein malnutrition, edema, and reduced growth.</p>
        <p>Protein substitution by parenteral albumin infusions is required for heavy and constant proteinuria (10&#x000a0;to 100 g/L).&#x000a0; Usually&#x000a0;(3&#x000a0;to 4 g/kg per day of albumin), 20% albumin solution together with a bolus of intravenous furosemide (0.5 mg/kg) using central venous catheters is given.</p>
        <p>
<bold>Medications&#x000a0;</bold>
</p>
        <p>Angiotensin-converting enzyme (ACE) inhibitors and indomethacin are used to reduce the protein excretion in urine.&#x000a0;</p>
        <p>Thyroxine substitution is recommended in congenital nephrotic syndrome patients for&#x000a0;low levels of serum thyroid-binding globulin and thyroxine. Thyroxine can be started with 6.25&#x000a0;to 12.5 &#x003bc;g/day and can be adjusted as per TSH levels.</p>
        <p>
<bold>Anticoagulation&#x000a0;</bold>
</p>
        <p>Imbalance of plasma coagulation factor levels due to protein loss in urine results in a risk for thromboses. Aspirin and dipyridamole&#x000a0;have been&#x000a0;recommended for anticoagulation therapy.&#x000a0;</p>
        <p>
<bold>Nutrition&#x000a0;</bold>
</p>
        <p>Congenital nephrotic syndrome is treated with a high-energy (130 kcal/kg per day) and a high-protein (3&#x000a0;to 4 g/kg per day) diet. First, Breast milk and milk formulas are used. Excessive protein is used as a&#x000a0; casein-based protein. A mixture of rapeseed and sunflower oils is given as lipid supplementation. Vitamin D2 (400 IU/day), magnesium (50 mg/day) and calcium (500&#x000a0;to 1,000 mg/day) are given. Daily water intake is 100&#x000a0;to 130 mL/kg.&#x000a0;</p>
        <p>
<bold>Nephrectomy&#x000a0;&#x000a0;</bold>
</p>
        <p>One approach is to do a unilateral nephrectomy to reduce protein loss and decrease the frequency of the albumin infusion.&#x000a0;Another approach is to do an early bilateral nephrectomy and start peritoneal dialysis.&#x000a0;When the baby is 7 kg of weight, bilateral nephrectomy is done, and start peritoneal dialysis.<xref ref-type="bibr" rid="article-132261.r8">[8]</xref>&#x000a0;Renal transplantation with the extraperitoneal placement of the kidney graft is performed later when the child weighs more than 9 kg. The third approach is to perform early, preemptive kidney transplantation with an intraperitoneal placement and removing the nephrotic kidneys at the same operation.</p>
        <p>Renal transplantation</p>
        <p>Congenital nephrotic syndrome children are usually transplanted at 1&#x000a0;to 2 years of age</p>
        <p>
<bold>Treatment Summary</bold>
</p>
        <table-wrap id="article-132261.table1" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Albumin Infusions&#x000a0;</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0;20% albumin infusions&#x000a0;parenterally&#x000a0; (3&#x000a0;to 4 g/kg per day of albumin)</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Nutrition</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Nutrition Protein supplementation (3&#x000a0;to 4 g/kg per day)</p>
<p>Lipid supplementation (rapeseed/sunflower oil)</p>
<p>Diet&#x000a0;Hypercaloric&#x000a0; (130 kcal/kg per day) Vitamins A, D, E,&#x000a0; water-soluble vitamins</p>
<p>Calcium and magnesium supplementation</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Medications</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Thyroxin supplementation</p>
<p>Antiproteinuric drugs that reduce protein excretion (ACE-inhibitor, indomethacin) Anticoagulation (warfarin, aspirin, ATIII-infusion)</p>
<p>Parenteral antibiotics when bacterial infection suspected</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Nephrectomy and Peritoneal Dialysis</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>When the baby is 7 kg of weight, bilateral nephrectomy is done, starting peritoneal dialysis.</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Renal Transplantation&#x000a0;</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Renal transplantation with the extraperitoneal placement of the kidney graft is performed later when the child weighs more than 9 kg.</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-132261.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The Finnish type's genetic form of congenital nephrotic syndrome can be divided&#x000a0;as&#x000a0;autosomal dominant&#x000a0;or&#x000a0; (AD) autosomal recessive (AR).<xref ref-type="bibr" rid="article-132261.r3">[3]</xref></p>
        <table-wrap id="article-132261.table2" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Inheritance </bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Gene </bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Locus </bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Protein </bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Phenotype </bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Autosomal Dominant</bold></p>
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>WT1</p>
</td>
                <td rowspan="1" colspan="1">
<p>11P13</p>
</td>
                <td rowspan="1" colspan="1">
<p>Wilms tumor 1 protein</p>
</td>
                <td rowspan="1" colspan="1">
<p>Frasier syndrome, WAGR syndrome,&#x000a0;Denys-Drash syndrome&#x000a0;</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>LMX1B</p>
</td>
                <td rowspan="1" colspan="1">
<p>17q11</p>
</td>
                <td rowspan="1" colspan="1">
<p>Lim homeobox transcription factor 1-&#x003b2;</p>
</td>
                <td rowspan="1" colspan="1">
<p>Nail-patella syndrome&#x000a0;</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Autosomal Recessive</bold></p>
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>NPHS1</p>
</td>
                <td rowspan="1" colspan="1">
<p>19q13.1</p>
</td>
                <td rowspan="1" colspan="1">
<p>Nephrin</p>
</td>
                <td rowspan="1" colspan="1">
<p>Congenital nephrotic syndrome of the Finnish type. (CNF)</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>NPHS2&#x000a0;</p>
</td>
                <td rowspan="1" colspan="1">
<p>1q25-31</p>
</td>
                <td rowspan="1" colspan="1">
<p>Podocin</p>
</td>
                <td rowspan="1" colspan="1">
<p>Idiopathic congenital nephrotic syndrome steroid-resistant nephrotic syndrome. (SRNS)</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>LAMB2&#x000a0;</p>
</td>
                <td rowspan="1" colspan="1">
<p>3p21</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0;Laminin &#x003b2;2 chain</p>
</td>
                <td rowspan="1" colspan="1">
<p>Pierson's syndrome</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>PLCE1&#x000a0;</p>
</td>
                <td rowspan="1" colspan="1">
<p>10q23</p>
</td>
                <td rowspan="1" colspan="1">
<p>Phospholipase C epsilon 1</p>
</td>
                <td rowspan="1" colspan="1">
<p>steroid-resistant nephrotic syndrome (SRNS), diffuse mesangial sclerosis (DMS)</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Unknown</bold></p>
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0;Galloway-Mowat syndrome (GMS)</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Denys-Drash syndrome&#x000a0;(DDS) is characterized by&#x000a0;male pseudo-hermaphroditism, Wilms tumor, and early-onset nephrotic syndrome that progress rapidly to end-stage renal disease.<xref ref-type="bibr" rid="article-132261.r9">[9]</xref>&#x000a0;Renal biopsy mostly reveals diffuse mesangial sclerosis (DMS) of glomeruli.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref></p>
        <p>Frasier syndrome (FS) is characterized by&#x000a0;progressive glomerulopathy, male pseudo-hermaphroditism, and gonadoblastomas.&#x000a0;Proteinuria is usually detected between 2 and 6&#x000a0;years of age. The disease has a slower progression to end-stage renal disease than DDS. Renal biopsy shows FSGS.<xref ref-type="bibr" rid="article-132261.r9">[9]</xref></p>
        <p>Pierson's syndrome is&#x000a0;characterized by congenital nephrotic syndrome/diffuse mesangial sclerosis,&#x000a0;microcoria (small pupils),&#x000a0;impairments of vision, and muscular hypotonia. Children with Pierson syndrome usually die from renal failure within days or weeks after birth.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref></p>
        <p>Nail-patella syndrome&#x000a0;is&#x000a0;characterized by&#x000a0;dysplastic or absent finger- and toenails, small or absent patellar, and kidney involvement ranging from mild proteinuria to end-stage renal failure.<xref ref-type="bibr" rid="article-132261.r10">[10]</xref>&#x000a0;</p>
        <p>Galloway Mowat syndrome&#x000a0;(GMS) is characterized by microcephaly with various central nervous system anomalies and early-onset nephrotic syndrome.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref>&#x000a0;Other additional findings include&#x000a0;microphthalmos, epicanthic folds, a narrow slopping forehead, a highly arched palate, large low-set floppy ears, a small midface, a beaked nose, thin lips, clenched hands, and arachnodactyly.<xref ref-type="bibr" rid="article-132261.r11">[11]</xref></p>
        <p>Infectious causes of congenital nephrotic syndrome are congenital syphilis, toxoplasmosis, or viral infections as cytomegalovirus. The prognosis is good.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref></p>
        <p>Congenital syphilis causes congenital nephrotic syndrome commonly in developing countries.&#x000a0;Congenital syphilis presents with fever,&#x000a0;anemia,&#x000a0;persistent rhinitis, hepatitis, hepatosplenomegaly, neurosyphilis, desquamations, and erythematous patches with superficial bullae. Renal involvement varies from microscopic hematuria to nephrotic syndrome. The nephrotic syndrome usually appears between 2 and 3 months.&#x000a0;Membranous nephropathy is a common finding in renal biopsy. The immune system is involved in the pathogenesis, as evidenced by&#x000a0;immune deposits in the region of the glomerular basement membrane. Prognosis is good as antimicrobial therapy. Usually, penicillin is curative.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref></p>
        <p>Congenital toxoplasmosis is a rare cause of nephrotic syndrome. It is usually caused by intrauterine toxoplasmosis infection in the mother. Congenital toxoplasmosis is&#x000a0;associated with massive proteinuria, hypoalbuminemia, anasarca, and positive&#x000a0;IgM serum antibody for toxoplasmosis. &#x000a0;In congenital nephrotic syndrome caused by toxoplasmosis, diffuse mild increase in mesangial cells and&#x000a0;extensive glomerulosclerosis is a common finding in renal biopsy.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref>&#x000a0;After spiramycin treatment for three weeks, proteinuria is negative, and serum toxoplasmosis IgM antibody titer vanish.&#x000a0;</p>
        <p>In western countries, cytomegalovirus infection is one of the common causes of congenital infections. Incidence varies between 0.15% and 2%. Cytomegalovirus infection presents with anemia, thrombocytopenia,&#x000a0;pulmonary infection, and congenital nephrotic syndrome. Diagnosis is&#x000a0;confirmed by the detection of viral DNA by quantitative PCR assay. Diffuse mesangial sclerosis (DMS) is often seen on histological examination on renal biopsy. Tubular cells and glomeruli may show cytomegalic inclusion bodies.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref>&#x000a0;Clinical response to ganciclovir therapy for 3 weeks is excellent.<xref ref-type="bibr" rid="article-132261.r12">[12]</xref></p>
        <p>Non-genetic causes of&#x000a0;congenital nephrotic syndrome are&#x000a0;neonatal alloimmunization,&#x000a0;renal vein thrombosis, maternal systemic lupus erythematosus, and mercury poisoning.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref></p>
        <p>Neonatal alloimmunization Mother has&#x000a0;mutations in the metallomembrane endopeptidase gene, which encodes the podocyte protein neutral endopeptidase (NEP). Pathogenesis involves the absence of the&#x000a0;neutral endopeptidase&#x000a0;(NEP) in the mother that induces an alloimmunization process against the NEP of fetal cells.&#x000a0;Pregnant mothers with a deficiency of&#x000a0;neutral endopeptidase (NEP) produce anti&#x02013;neutral endopeptidase (NEP) antibodies resulting in fetal podocyte insult and nephron loss.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref></p>
      </sec>
      <sec id="article-132261.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The course of the congenital nephrotic syndrome of the Finnish type is progressive, leads to end-stage renal disease by 2-3 years of age. Prognosis is worse in NPHS1 gene mutations compared with NPHS2 gene mutations. Prognosis is different in patients with different ethnic backgrounds. Female patients with NPHS1 mutations have longer survival than their male counterparts.<xref ref-type="bibr" rid="article-132261.r3">[3]</xref>&#x000a0;Kidney transplantation is the only curative treatment in most cases.&#x000a0;Overall, the results of kidney transplantation in congenital nephrotic syndrome are quite good. The patient's 5-year survival rate is over 90%, and the graft survival rate is over 80%.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref></p>
      </sec>
      <sec id="article-132261.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Congenital nephrotic syndrome is more susceptible to infection with&#x000a0;encapsulated organisms such as <italic toggle="yes">Haemophilus influenzae</italic>, <italic toggle="yes">Escherichia coli</italic>, and <italic toggle="yes">Streptococcus</italic>&#x000a0;due to losses of&#x000a0;alternative complement pathway components into the urine.<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
        <p>Thromboembolism&#x000a0;due to urinary loss of antithrombin III and increased synthesis of procoagulant factors by the liver. Types of thrombosis include central sinus thrombosis, deep vein thrombosis, renal vein thrombosis, and pulmonary embolism.<xref ref-type="bibr" rid="article-132261.r4">[4]</xref></p>
        <p>Failure to thrive,&#x000a0;protein malnutrition, and vitamin deficiency.</p>
        <p>Low levels of thyroxin and serum thyroid-binding globulin due to protein excretion.<xref ref-type="bibr" rid="article-132261.r2">[2]</xref></p>
      </sec>
      <sec id="article-132261.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Congenital nephrotic syndrome (CNS) is defined&#x000a0;when it presents within three months of birth. It consists of heavy proteinuria, edema, hypoalbuminemia, hypogammaglobulinemia, hypercoagulability, and hyperlipidemia.<xref ref-type="bibr" rid="article-132261.r1">[1]</xref>&#x000a0;Management is very challenging as patients are prone to complications such as infection, thrombosis, and failure to thrive.&#x000a0;</p>
        <p>The recommendation is that patients with congenital nephrotic syndrome require referral to tertiary pediatric nephrology center and treatment by&#x000a0;an interprofessional&#x000a0;team that&#x000a0;includes pediatric nephrologists, pediatric nephrology nurses, pediatric hemodialysis nurses, pediatric peritoneal dialysis nurses,&#x000a0;pediatric renal dieticians, pediatric renal transplant surgeons, renal pharmacists, neonatologist and child psychologists and social workers. Through interprofessional care coordination, open communication, and information sharing, patients will have a better chance at improved outcomes. [Level 5]</p>
      </sec>
      <sec id="article-132261.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=132261&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=132261">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/congenital-nephrotic-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=132261">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/132261/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=132261">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-132261.s15">
        <title>References</title>
        <ref id="article-132261.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Penaflor</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Congenital nephrotic syndrome.</article-title>
            <source>Pediatr Rev</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <pub-id pub-id-type="pmid">11139645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>Congenital nephrotic syndrome.</article-title>
            <source>Neonatal Netw</source>
            <year>2007</year>
            <season>Jan-Feb</season>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-55</page-range>
            <pub-id pub-id-type="pmid">17285887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The etiology of congenital nephrotic syndrome: current status and challenges.</article-title>
            <source>World J Pediatr</source>
            <year>2016</year>
            <month>May</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-58</page-range>
            <pub-id pub-id-type="pmid">26961288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rheault</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Nephrotic and nephritic syndrome in the newborn.</article-title>
            <source>Clin Perinatol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>605</fpage>
            <page-range>605-18</page-range>
            <pub-id pub-id-type="pmid">25155730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reynolds</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Oswald</surname>
                <given-names>RJA</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic and Management Challenges in Congenital Nephrotic Syndrome.</article-title>
            <source>Pediatric Health Med Ther</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>157</fpage>
            <page-range>157-167</page-range>
            <pub-id pub-id-type="pmid">31908565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ranganathan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pathology of Podocytopathies Causing Nephrotic Syndrome in Children.</article-title>
            <source>Front Pediatr</source>
            <year>2016</year>
            <volume>4</volume>
            <fpage>32</fpage>
            <pub-id pub-id-type="pmid">27066465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patrakka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kestil&#x000e4;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wartiovaara</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ruotsalainen</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tissari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lenkkeri</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>M&#x000e4;nnikk&#x000f6;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Visap&#x000e4;&#x000e4;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Holmberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rapola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tryggvason</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jalanko</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients.</article-title>
            <source>Kidney Int</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>972</fpage>
            <page-range>972-80</page-range>
            <pub-id pub-id-type="pmid">10972661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kestil&#x000e4;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>J&#x000e4;rvel&#x000e4;</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Prenatal diagnosis of congenital nephrotic syndrome (CNF, NPHS1).</article-title>
            <source>Prenat Diagn</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>323</fpage>
            <page-range>323-4</page-range>
            <pub-id pub-id-type="pmid">12673639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niaudet</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Genetic forms of nephrotic syndrome.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>12</issue>
            <fpage>1313</fpage>
            <page-range>1313-8</page-range>
            <pub-id pub-id-type="pmid">15503167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Witzgall</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Nail-patella syndrome.</article-title>
            <source>Pflugers Arch</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>469</volume>
            <issue>7-8</issue>
            <fpage>927</fpage>
            <page-range>927-936</page-range>
            <pub-id pub-id-type="pmid">28681095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Galloway-Mowat syndrome: prenatal ultrasound and perinatal magnetic resonance imaging findings.</article-title>
            <source>Taiwan J Obstet Gynecol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>212</fpage>
            <page-range>212-6</page-range>
            <pub-id pub-id-type="pmid">21791310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132261.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Besbas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bayrakci</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Kale</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cengiz</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Akcoren</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Akinci</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kilic</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bakkaloglu</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cytomegalovirus-related congenital nephrotic syndrome with diffuse mesangial sclerosis.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2006</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>740</fpage>
            <page-range>740-2</page-range>
            <pub-id pub-id-type="pmid">16523262</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
